Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Intermediate Repeat Expansion in ATXN2 Gene as a Risk Factor in ALS and FTD Spanish Population

Version 1 : Received: 21 December 2023 / Approved: 22 December 2023 / Online: 22 December 2023 (12:28:30 CET)

A peer-reviewed article of this Preprint also exists.

Borrego-Hernández, D.; Vázquez-Costa, J.F.; Domínguez-Rubio, R.; Expósito-Blázquez, L.; Aller, E.; Padró-Miquel, A.; García-Casanova, P.; Colomina, M.J.; Martín-Arriscado, C.; Osta, R.; Cordero-Vázquez, P.; Esteban-Pérez, J.; Povedano-Panadés, M.; García-Redondo, A. Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population. Biomedicines 2024, 12, 356. Borrego-Hernández, D.; Vázquez-Costa, J.F.; Domínguez-Rubio, R.; Expósito-Blázquez, L.; Aller, E.; Padró-Miquel, A.; García-Casanova, P.; Colomina, M.J.; Martín-Arriscado, C.; Osta, R.; Cordero-Vázquez, P.; Esteban-Pérez, J.; Povedano-Panadés, M.; García-Redondo, A. Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population. Biomedicines 2024, 12, 356.

Abstract

Intermediate CAG expansions in the gene ataxin-2 (ATXN2) are a known risk factor for ALS, but little is known about their role in FTD risk. Moreover, their contribution to the risk and phenotype of patients might vary in populations with different genetic background. The aim of this study was to assess the relationship of intermediate CAG expansions in ATXN2 with the risk and phenotype of ALS and FTD in the Spanish population. Repeat-Primed PCR was performed in 620 ALS and 137 FTD patients in three referral centers of Spain to determine the exact number of CAG repeats. In our cohort, ≥27 CAG repeats in ATXN2 was associated with a higher risk of developing ALS (odds ratio [OR] = 2.666 [1.471-4.882]; p = 0.0013), but not FTD (odds ratio [OR] = 1.446 [0.558-3.574]; p = 0.44). Moreover, ALS patients with ≥27 CAG repeats in ATXN2 showed shorter survival rate compared to those with <27 repeats (hazard ratio [HR] 1.74 [1.18, 2.56], p = 0.005), more frequent limb onset (odds ratio [OR] = 2.34 [1.093-4.936]; p = 0.028), as well as family history of ALS (odds ratio [OR] = 2.538 [1.375-4.634]; p = 0.002). Intermediate CAG expansions of ≥27 repeats in ATXN2 are associated with ALS risk, but not with FTD, in the Spanish population. ALS patients carrying an intermediate expansion in ATXN2 show more frequent limb onset, but worse prognosis than those without expansions. In patients carrying C9orf72 expansions, the intermediate ATXN2 expansion might increase the penetrance and modify the phenotype.

Keywords

amyotrophic lateral sclerosis; ATXN2, risk factor; frontotemporal dementia; mutation; poli-Q expansion

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.